25 May 2013
Keywords: vernalis, novartis, extend, collaboration, uk, says, institutes
Article | 16 August 2004
The UK's Vernalis says that the Novartis Institutes for BioMedicalResearch has exercised its option to license exclusive rights to its
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 August 2004
24 May 2013
© 2013 thepharmaletter.com